Hideki Ishihara

1.3k total citations
58 papers, 1.0k citations indexed

About

Hideki Ishihara is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hideki Ishihara has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hideki Ishihara's work include Cancer-related Molecular Pathways (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Breast Cancer Treatment Studies (5 papers). Hideki Ishihara is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Breast Cancer Treatment Studies (5 papers). Hideki Ishihara collaborates with scholars based in Japan, United States and Canada. Hideki Ishihara's co-authors include Satoshi Nakayama, Shinzaburo Noguchi, Yasuo Miyoshi, Yasuhiro Tamaki, Tomoko Matsushima, G Delespesse, Myriam Armant, Nadia Vezzio, Manuel Rubio and Tetsuya Taguchi and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Hideki Ishihara

55 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideki Ishihara Japan	19	434	318	200	198	194	58	1.0k
Cinzia Bagalá Italy	18	629 1.4×	484 1.5×	251 1.3×	177 0.9×	198 1.0×	36	1.3k
Albertus T.J. Wierenga Netherlands	22	659 1.5×	374 1.2×	283 1.4×	93 0.5×	255 1.3×	34	1.3k
Naoki Watanabe Japan	21	527 1.2×	220 0.7×	380 1.9×	103 0.5×	124 0.6×	72	1.2k
Naoko Okayama Japan	20	643 1.5×	403 1.3×	188 0.9×	148 0.7×	288 1.5×	70	1.3k
Graziella M. Abu‐Jawdeh United States	19	642 1.5×	209 0.7×	158 0.8×	135 0.7×	235 1.2×	23	1.2k
Liang Hu China	19	669 1.5×	309 1.0×	127 0.6×	157 0.8×	321 1.7×	31	1.2k
D A Kirschmann United States	11	634 1.5×	220 0.7×	166 0.8×	143 0.7×	217 1.1×	15	1.0k
Edward Carter United Kingdom	17	436 1.0×	168 0.5×	98 0.5×	176 0.9×	118 0.6×	54	956
Mark DeWitte United States	13	323 0.7×	532 1.7×	375 1.9×	91 0.5×	99 0.5×	21	1.1k
Geoffrey Hall United Kingdom	16	427 1.0×	394 1.2×	287 1.4×	146 0.7×	193 1.0×	30	1.2k

Countries citing papers authored by Hideki Ishihara

Since Specialization

Citations

This map shows the geographic impact of Hideki Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Ishihara more than expected).

Fields of papers citing papers by Hideki Ishihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Ishihara. The network helps show where Hideki Ishihara may publish in the future.

Co-authorship network of co-authors of Hideki Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Ishihara. A scholar is included among the top collaborators of Hideki Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Ishihara. Hideki Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nishimura, Koichi, Hideki Ishihara, Hironori Fukuda, et al.. (2025). Impact of first-line dual immuno-oncology combination therapy versus immuno-oncology plus tyrosine kinase inhibitor on outcomes of second-line VEGFR-TKI in advanced RCC: a real-world multi-institutional analysis. International Urology and Nephrology. 58(3). 911–920.

Tsujimoto, Masahiko, et al.. (2024). Flow cytometric analysis for Ki67 assessment in formalin-fixed paraffin-embedded breast cancer tissue. BMC Biology. 22(1). 181–181.

Uwamino, Yoshifumi, et al.. (2023). The utility of smartphone-based quantitative analysis of SARS-CoV-2-specific antibody lateral flow assays. Diagnostic Microbiology and Infectious Disease. 108(3). 116166–116166. 3 indexed citations

Wakabayashi, Masayuki, Atsuko Ishida, Jangsoon Lee, et al.. (2017). MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer. Biochemical and Biophysical Research Communications. 489(4). 484–489. 9 indexed citations

Gohda, Keigo, Michelle L. Davis, W. Fraser Symmans, et al.. (2013). Novel Functional Assay for Spindle-Assembly Checkpoint by Cyclin-Dependent Kinase Activity to Predict Taxane Chemosensitivity in Breast Tumor Patient. Journal of Cancer. 4(9). 697–702. 5 indexed citations

Engels, C.C., Esther M. de Kruijf, Gabi W. van Pelt, et al.. (2013). The prognostic value of apoptotic and proliferative markers in breast cancer. Breast Cancer Research and Treatment. 142(2). 323–339. 22 indexed citations

Itamochi, Hiroaki, Tomokazu Yoshida, Cheryl L. Walker, et al.. (2011). Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27. Gynecologic Oncology. 122(3). 641–647. 20 indexed citations

Ueki, Jun, Michiaki Mishima, Koichiro Tatsumi, et al.. (2011). The current situation and the perspective of respiratory care in Japanese COPD patients revealed by Japanese White Paper on home respiratory care 2010 – COPD subgroup analysis. European Respiratory Journal. 38(Suppl 55). p1249–p1249. 1 indexed citations

Yamamoto, Noriaki, Takahiro Nakayama, Masahiro Kajita, et al.. (2011). Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay. Breast Cancer Research and Treatment. 132(1). 165–173. 72 indexed citations

10.

Kurebayashi, Junichi, Naoki Kanomata, Yuji Kozuka, et al.. (2011). The Cell Cycle Profile Test is a Prognostic Indicator for Breast Cancer Patients Treated With Postoperative 5-Fluorouracil-Based Chemotherapy. Japanese Journal of Clinical Oncology. 41(6). 739–746. 1 indexed citations

11.

Nes, Johanna G. H. van, Vincent T.H.B.M. Smit, Hein Putter, et al.. (2009). Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients. British Journal of Cancer. 100(3). 494–500. 11 indexed citations

12.

Onozato, Yoshikuni, et al.. (2008). Magnifying endoscopic findings of early duodenal adenocarcinoma in relation to the pathological findings. Endoscopy. 40(S 02). E92–E93. 3 indexed citations

13.

Nakayama, Satoshi, Yasuo Miyoshi, Hideki Ishihara, & Shinzaburo Noguchi. (2007). Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Research and Treatment. 112(3). 405–410. 82 indexed citations

14.

Koide, Yukio, Hideki Ishihara, & Fumio Kanda. (2007). Nodular‐type muscle sarcoidosis developing after a dog bite. Muscle & Nerve. 37(2). 262–264. 2 indexed citations

15.

Miyoshi, Yasuo, Satoshi Nakayama, Satoshi Tanaka, et al.. (2006). High expression of ubiquitin carboxy‐terminal hydrolase‐L1 and ‐L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Science. 97(6). 523–529. 82 indexed citations

16.

Ishihara, Hideki, Tomokazu Yoshida, Yuko Kawasaki, et al.. (2005). A new cancer diagnostic system based on a CDK profiling technology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1741(3). 226–233. 23 indexed citations

17.

Kobayashi, Hironori, et al.. (2003). A New type of Protein Profiling System using CPDIB (Crude Protein Direct Blotting) assay. Journal of the Japan Society for Precision Engineering. 69(12). 1796–1800. 1 indexed citations

18.

Itamochi, Hiroaki, et al.. (1995). An optimal regimen of G-CSF (granulocyte colony-stimulating factor) treatment after anticancer chemotherapy for patients with gynecologic malignancy. 30(5). 776–780. 1 indexed citations

19.

Byun, Dae‐Gyoo, Christian E. Demeure, U. Shu, et al.. (1994). In vitro maturation of neonatal human CD8 T lymphocytes into IL-4- and IL-5-producing cells.. The Journal of Immunology. 153(11). 4862–4871. 23 indexed citations

20.

Morii, Takashi, et al.. (1990). Protective immunity toLeucocytozoon caulleryi in chickens by a killed vaccine. Parasitology Research. 76(7). 630–632. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact